Overactive Bladder Management: Challenges and Opportunities
Pharmacy Times Office of Continuing Professional Education
Overactive Bladder Management: Challenges and Opportunities
Mary Barna Bridgeman, PharmD, BCPS, CGP
Clinical Assistant Professor
Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey; Piscataway, NJ
Internal Medicine Clinical Pharmacist
Capital Health Regional Medical Center; Trenton, NJ
Christina Taft, PharmD
Post-Graduate Year-1 Pharmacy Resident
Capital Health Regional Medical Center; Trenton, NJ
Mary Barna Bridgeman, PharmD, BCPS, CGP, and Christina Taft, PharmD, have no relevant affiliations or financial relationships to disclose related to this acitivity.
Judy V. Lum, MPA; Elena Beyzarov, PharmD; Ann C. Lichti, CCMEP; and Donna Fausak of the Pharmacy Times Office of Continuing Professional Education have no relevant affiliations or financial relationships to disclose related to this activity.
Bea Riemschneider, Jennifer Barrio, and David Allikas of Pharmacy Times Editorial have no relevant affiliations or financial relationships to disclose related to this activity.
Educational Objectives
Upon completion of this educational activity, participants should be able to:
- Recognize the prevalence and burden associated with overactive bladder (OAB) syndrome.
- Understand the impact of OAB on patients and their quality of life.
- Evaluate current and emerging agents for the management of OAB and their role in the treatment paradigm.
- Counsel patients effectively about their OAB medication, side effects, and the importance of adherence.
Target audience: Pharmacists
Type of activity: Knowledge
Release date: February 10, 2012
Expiration date: February 10, 2014
Estimated time to complete activity: 1.5 hours
Fee: This lesson is free online
Click here to view this activity.
